Chrousos Phaedra 4
4 · Vanda Pharmaceuticals Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Common Stock
2022-06-16+12,006→ 24,931 total - Award
Stock Option (Right to Buy)
2022-06-16+24,707→ 24,707 totalExercise: $9.37Exp: 2032-06-15→ Common Stock (24,707 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on June 16, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.